Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARK Kraaifontein PMTCT trial
PACTR2009070001314037Unknown
- Sponsor
- Ark
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of dolutegravir + maraviroc + lamivudine in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Ark. Primary endpoint: Infant PCR uptake. Status: unknown.
02
Drugs
dolutegravir + maraviroc + lamivudine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on PACTR2009070001314037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR2009070001314037.